128 related articles for article (PubMed ID: 35537935)
1. Lipase elevation on admission predicts worse clinical outcomes in patients with COVID-19.
Kiyak M; Düzenli T
Pancreatology; 2022 Jun; 22(5):665-670. PubMed ID: 35537935
[TBL] [Abstract][Full Text] [Related]
2. Hyperlipasemia in absence of acute pancreatitis is associated with elevated D-dimer and adverse outcomes in COVID 19 disease.
Ahmed A; Fisher JC; Pochapin MB; Freedman SD; Kothari DJ; Shah PC; Sheth SG
Pancreatology; 2021 Jun; 21(4):698-703. PubMed ID: 33741267
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Outcomes in COVID-19 Patients With Varying Degrees of Hyperlipasemia.
Benias PC; Inamdar S; Wee D; Liu Y; Buscaglia JM; Satapathy SK; Trindade AJ;
Pancreas; 2021 Oct; 50(9):1310-1313. PubMed ID: 34860817
[TBL] [Abstract][Full Text] [Related]
4. Does Hyperlipasemia Predict Worse Clinical Outcomes in COVID-19? A Multicenter Retrospective Cohort Study.
Singh RR; Chhabra P; Kumta NA
J Clin Gastroenterol; 2022 Mar; 56(3):e227-e231. PubMed ID: 34294655
[TBL] [Abstract][Full Text] [Related]
5. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.
Khan MU; Mushtaq K; Alsoub DH; Iqbal P; Ata F; Chaudhry HS; Iqbal F; Balaraju G; Maslamani MAA; Varughese B; Singh R; Ejji KA; Kaabi SA; Kamel YM; Butt AA
World J Gastroenterol; 2021 Dec; 27(46):7995-8009. PubMed ID: 35046626
[TBL] [Abstract][Full Text] [Related]
6. Lipase elevation in serum of COVID-19 patients: frequency, extent of increase and clinical value.
Caruso S; Aloisio E; Dolci A; Panteghini M
Clin Chem Lab Med; 2022 Jan; 60(1):135-142. PubMed ID: 34687597
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of patients with acute pancreatitis associated with SARS-CoV-2 (COVID-19); The importance of lipase/lymphocyte ratio in predicting mortality.
Haydar FG; Otal Y; Avcioglu G
Bratisl Lek Listy; 2022; 123(6):428-434. PubMed ID: 35576544
[TBL] [Abstract][Full Text] [Related]
9. Development of pancreatic injuries in the course of COVID-19.
Akkus C; Yilmaz H; Mizrak S; Adibelli Z; Akdas O; Duran C
Acta Gastroenterol Belg; 2020; 83(4):585-592. PubMed ID: 33321015
[TBL] [Abstract][Full Text] [Related]
10. Marked Elevation of Lipase in COVID-19 Disease: A Cohort Study.
Barlass U; Wiliams B; Dhana K; Adnan D; Khan SR; Mahdavinia M; Bishehsari F
Clin Transl Gastroenterol; 2020 Jul; 11(7):e00215. PubMed ID: 32764201
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
[TBL] [Abstract][Full Text] [Related]
12. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.
DeBolt CA; Bianco A; Limaye MA; Silverstein J; Penfield CA; Roman AS; Rosenberg HM; Ferrara L; Lambert C; Khoury R; Bernstein PS; Burd J; Berghella V; Kaplowitz E; Overbey JR; Stone J
Am J Obstet Gynecol; 2021 May; 224(5):510.e1-510.e12. PubMed ID: 33221292
[TBL] [Abstract][Full Text] [Related]
13. Lipase Elevation in Patients With COVID-19.
McNabb-Baltar J; Jin DX; Grover AS; Redd WD; Zhou JC; Hathorn KE; McCarty TR; Bazarbashi AN; Shen L; Chan WW
Am J Gastroenterol; 2020 Aug; 115(8):1286-1288. PubMed ID: 32496339
[TBL] [Abstract][Full Text] [Related]
14. Sex-Based Differences in COVID-19 Outcomes.
Tejpal A; Gianos E; Cerise J; Hirsch JS; Rosen S; Kohn N; Lesser M; Weinberg C; Majure D; Satapathy SK; Bernstein D; Barish MA; Spyropoulos AC; Brown RM
J Womens Health (Larchmt); 2021 Apr; 30(4):492-501. PubMed ID: 33885345
[No Abstract] [Full Text] [Related]
15. Intensive Care Unit Admissions During the First 3 Months of the COVID-19 Pandemic in Poland: A Single-Center, Cross-Sectional Study.
Kokoszka-Bargieł I; Cyprys P; Rutkowska K; Madowicz J; Knapik P
Med Sci Monit; 2020 Sep; 26():e926974. PubMed ID: 32979262
[TBL] [Abstract][Full Text] [Related]
16. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
17. Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity.
Aminian A; Fathalizadeh A; Tu C; Butsch WS; Pantalone KM; Griebeler ML; Kashyap SR; Rosenthal RJ; Burguera B; Nissen SE
Surg Obes Relat Dis; 2021 Jan; 17(1):208-214. PubMed ID: 33243670
[TBL] [Abstract][Full Text] [Related]
18. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
